Patient info Open main menu

Crescent Pharma Antiseptic Gargle 0.71% w/v Mouthwash – Summary of Product Characteristics (SmPC) for healthcare professionals

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
0.71% w/v
ATC code:

Summary of Product Characteristics (SmPC) - Crescent Pharma Antiseptic Gargle 0.71% w/v mouthwash

1 NAME OF THE MEDICINAL PRODUCT

Crescent Pharma Antiseptic Gargle 0.71% w/v Mouthwash

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Phenol BP 0.71% w/v

For the full list of excipients, see section 6.1.

3 PHARMACEUTICAL FORM

Mouthwash

Clear, bright red liquid with odour of peppermint and phenol.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

For relief of sore throats symptoms, including those associated with cold and flu, bad breath, mouth ulcers, painful gums.

4.2 Posology and method of administration

Posology

Adults, children and the elderly.

For relief of sore throats symptoms and bad breath:

Dilute one part of the solution with three parts of warm water.

Thoroughly rinse the mouth or gargle with the diluted product for up to 20 seconds morning and evening.

For mouth ulcers:

Dab undiluted on the affected area three times daily. If symptoms persist for more than 14 days consult your dentist.

4.3 Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

4.4 Special warnings and precautions for use

If symptoms persist for more than 14 days a doctor should be consulted.

DO NOT SWALLOW THIS SOLUTION

4.5 Interaction with other medicinal products and other forms of interaction

None known.

4.6 Fertility, pregnancy and lactation

There is no experience of the use of the product in pregnancy and lactation, however the product has been widely used for many years with no adverse effects.

4.7 Effects on ability to drive and use machines

Not known.

4.8 Undesirable effects

There are no adverse events reported.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9 Overdose

Serious adverse events are unlikely to result from overdosage of this product. Accidental ingestion: If a quantity (over 30ml) of neat Antiseptic Gargle and Mouthwash is swallowed accidentally, drink 0.5 to 1 litre of water immediately. If discomfort persists, seek medical advice.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Pharmacotherapeutic group: Throat preparations. Antiseptics, ATC code: R02AA19

Phenol act on all pathogenic micro-organisms similarly and to approximately the same degree - i.e. they are non-specific, their activity is not appreciably reduced by the presence of relatively large amounts of non-living organic matter, their relatively simple chemical constitution means that their use is not liable to encourage the emergence of strains of micro-organisms adapted to resist their action.

5.2 Pharmacokinetic properties

This medicinal product is for oromucosal use only. Significant absorption from this topical dosage form is considered unlikely.

5.3 Preclinical safety data

None stated.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Glycerine BP

Peppermint Oil BP

Amaranth Solution BP

Purified water

6.2 Incompatibilities

Not applicable.

6.3 Shelf life

3 Years

6.4 Special precautions for storage

Keep the container in the outer carton in order to protect from light.

6.5 Nature and contents of container

White flint glass bottles of 200ml, with a plastic cap.

Plastic container of 2000ml with a plastic cap.

Not all pack sizes may be marketed.

6.6 Special precautions for disposal

No special requirements.

7 MARKETING AUTHORISATION HOLDER

GlobeGen Laboratories Ltd,

1406 Coventry Road,

South Yardley,

Birmingham,

B25 8AE

United Kingdom

8 MARKETING AUTHORISATION NUMBER(S)

PL 41318/0034

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

14/01/2009

10 DATE OF REVISION OF THE TEXT

02/08/2021

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 20416/0570

Last revision stated in the text: 2 August 2021 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Crescent Pharma Antiseptic Gargle 0.71% w/v mouthwash

Strength 0.71% w/v
Pharmaceutical form Clear, bright red liquid with odour of peppermint and phenol.
Excipients Glycerine BP, Peppermint Oil BP, Amaranth Solution BP, Purified water
Shelf life 3 Years
Storage Keep the container in the outer carton in order to protect from light.
Drug group (ATC) Throat preparations. Antiseptics
  1. R Respiratory system drugs
    1. R02 Throat preparations
      1. R02A Throat preparations
        1. R02AA Antiseptic throat preparations
          1. R02AA19 phenol
Marketing authorisation PL 20416/0570 (first authorised 14 January 2009)
Marketing authorisation holder GlobeGen Laboratories Ltd

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.